BioSpectrum India, a leading B2B media platform in Lifesciences space since 2003, re-launched its ranking special edition in June 2019 after a gap of 2 years. We have delayed this survey and the ranking exercise in 2021 due to COVID-19, as companies were given an extended period to submit their financial returns till December 2021.

In this survey we looked at only the Biopharma Industry with companies specialising in Biologics/Blood products/ Recombinant products/ mAbs/ Vaccines/ Insulin.

We have highlighted the companies (both MNCs and domestic players) based on their achievements in the past financial years. A detailed questionnaire (survey form) was sent to the companies in biologicals space to capture the needed information for the analysis.

This was done during October 2021 to March 2022 (Sales revenues of all the companies are in Rs Crore). Companies shared information with us to the extent it was possible by them. We have collected information about listed companies from stock exchange, financial agencies and speaking with industry experts as well.

Click here for the full story....